Document:

EX-10.8

 Exhibit 10.8 

EMPLOYMENT AGREEMENT 

This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into
effective May 15, 2021 (the “Effective Date”), by and between Wm. Matthew Zuga (the “Executive”) and Acumen Pharmaceuticals, Inc. (the
“Company”) and supersedes and replaces any prior consulting agreement or employment letter between the Parties and any of their affiliates, including that certain Consulting Agreement between the Company and Executive dated
August 16, 2019, that certain Employment Agreement between Executive dated January 1, 2021, that certain Letter Agreement between the Company and Executive dated March 11, 2021 . 

WHEREAS, the Company desires to employ Executive and, in connection therewith, to compensate Executive
for Executive’s personal services to the Company; and 
 WHEREAS, Executive wishes to be employed
by the Company and provide personal services and certain covenants to the Company in return for certain compensation and benefits. 

Accordingly, in consideration of the mutual promises and covenants contained herein, the parties agree to the following: 

1. EMPLOYMENT BY THE COMPANY. 

1.1 Position. Subject to the terms set forth herein, the Company agrees to employ Executive, in the position of Chief
Financial Officer and Chief Business Officer, and Executive hereby accepts such employment. During the term of Executive’s employment with the Company, Executive will devote Executive’s best efforts and substantially all of his
business time and attention to the business of the Company. 
 1.2 Duties. Executive will initially report to the Chief
Executive Officer (the “CEO”) of the Company. Executive shall perform his duties under this Agreement initially principally out of his personal residence and the Company’s corporate offices in Charlottesville, VA and
offices in Carmel, IN or such other location as assigned by the Company. In addition, Executive shall make business trips to such places as may be necessary or advisable for the efficient operations of the Company. 

1.3 Company Policies and Benefits. The employment relationship between the parties shall also be subject to the
Company’s personnel policies and procedures as they may be interpreted, adopted, revised or deleted from time to time in the Company’s sole discretion. Executive will be eligible to participate on the same basis as similarly situated
employees in the Company’s benefit plans in effect from time to time during Executive’s employment. All matters of eligibility for coverage or benefits under any benefit plan shall be determined in accordance with the provisions of the
such plan. The Executive shall be entitled to paid vacation in accordance with the plans, policies, programs and practices of the Company applicable to its senior executives in effect from time to time, but in no event shall the Executive be
entitled to less than four (4) weeks of vacation per calendar year (pro-rated for any partial year of service). The Company reserves the right to change, alter, or terminate any benefit plan in its sole
discretion. Notwithstanding the foregoing, in the event that the terms of this Agreement differ from or are in conflict with the Company’s general employment policies or practices, this Agreement shall control. 

  
 1 

 2. COMPENSATION. 

2.1 Salary. Executive shall receive for services to be rendered hereunder an initial base salary of $ 380,000.00 on
annualized basis, subject to review and adjustment from time to time by the Company, and payable subject to standard federal and state payroll withholding requirements in accordance with the Company’s standard payroll practices
(“Base Salary”). 
 2.2 Annual Discretionary Bonus. Executive shall be eligible for a
discretionary annual calendar year performance bonus (the “Annual Bonus”) with an annual target of forty percent (40%) of Executive’s then-current Base Salary (the “Target Amount”). Whether or not
Executive is eligible for any Annual Bonus will be dependent upon the actual achievement by Executive and the Company of the applicable individual and corporate performance goals, as determined by the Board. No amount of any Annual Bonus is
guaranteed at any time and may be greater or lesser than the Target Amount and may be zero. Any Annual Bonus, if awarded, will be paid in a single installment paid at the same time annual bonuses are generally paid to other similarly-situated
employees of the Company and in any event no later than March 1st of the calendar year following the calendar year to which the Annual Bonus is applicable, and will be subject to deductions and withholdings. Executive’s eligibility for an
Annual Bonus and the Target Amount, if any, is subject to change in the discretion of the Board (or any authorized committee thereof). 

2.3 Expense Reimbursement. The Company will reimburse Executive for reasonable business expenses in accordance with the
Company’s standard expense reimbursement policy, as the same may be modified by the Board from time to time. The Company shall reimburse Executive for all customary and appropriate business-related expenses actually incurred and documented in
accordance with Company policy, as in effect from time to time . For the avoidance of doubt, to the extent that any reimbursements payable to Executive are subject to the provisions of Section 409A of the Internal Revenue Code of 1986, as
amended (the “Code”): (a) any such reimbursements will be paid no later than December 31 of the year following the year in which the expense was incurred, (b) the amount of expenses reimbursed in one year will not
affect the amount eligible for reimbursement in any subsequent year, and (c) the right to reimbursement under this Agreement will not be subject to liquidation or exchange for another benefit. 

2.4 Stock Option. On January 4, 2021, the Company granted to Executive an option to purchase 672,541 shares of the
Company’s common stock at $0.80 per share (the “Option”). The Option is governed by the terms and conditions of the Company’s Equity Incentive Plan (the “Plan”) and the option grant
agreement, and will vest 25% on the one-year anniversary of the date of grant, and thereafter over the ensuing 3 years in a series of thirty-six (36) successive
equal monthly installments, subject to your Continuous Service (as defined in the Plan) as of each such date. The Company confirms that as your Continuous Service has remained uninterrupted from the date of the grant through the date of this
Agreement, notwithstanding any change to your status as an employee or consultant. 

  
 2 

 3. CONFIDENTIAL INFORMATION,
INVENTIONS, NON-COMPETITION AND NON-SOLICITATION
OBLIGATIONS. As a condition of employment, Executive agrees to execute and abide by the Employee Confidential Information, Inventions, Non-Solicitation and Non- Competition Agreement, attached as Exhibit A which may be amended by the parties from time to time without regard to this Agreement (the “Confidential Information Agreement”). The
Confidential Information Agreement contains provisions that are intended by the parties to survive and do survive termination of this Agreement. 

4. OUTSIDE ACTIVITIES DURING
EMPLOYMENT. Except with the prior written consent of the Company, Executive will not, while employed by the Company, undertake or engage in any other employment, occupation or business enterprise
that would interfere with Executive’s responsibilities and the performance of Executive’s duties hereunder except for (i) reasonable time devoted to volunteer services for or on behalf of such religious, educational, non- profit and/or other charitable organization as Executive may wish to serve, (ii) reasonable time devoted to activities in the non-profit and business communities
consistent with Executive’s duties; and (iii) such other activities as may be specifically approved in writing by the Company. 

5. NO CONFLICT WITH EXISTING
OBLIGATIONS. Executive represents that Executive’s performance of all the terms of this Agreement and as an Executive of the Company do not and will not breach any agreement or obligation of
any kind made prior to Executive’s employment by the Company, including agreements or obligations Executive may have with prior employers or entities for which Executive has provided services. Executive has not entered into, and Executive
agrees that Executive will not enter into, any agreement or obligation, either written or oral, in conflict herewith. 
 6.
TERMINATION OF EMPLOYMENT. The parties acknowledge that Executive’s employment relationship with the Company is
at-will. Either Executive or the Company may terminate the employment relationship for any reason whatsoever at any time, with or without Cause or advance notice. The provisions in this Section govern the
amount of compensation, if any, to be provided to Executive upon termination of employment and do not alter this at-will status. 

6.1 Termination by the Company without Cause or Resignation by Executive for Good Reason. 

(a) The Company shall have the right to terminate Executive’s employment with the Company pursuant to this Section 6.1 at
any time without Cause (as defined in Section 6.2(b) below) by giving notice as described in Section 7.1 of this Agreement. A termination pursuant to Section 6.4 or 6.5 below is not a termination without Cause for purposes of
receiving the benefits described in this Section 6.1. 
 (b) In the event the Company terminates Executive’s employment
without Cause or Executive Resigns for Good Reason (as defined in Section 6.1(g) below), and provided that such termination constitutes a “separation from service” (as defined under Treasury Regulation
Section 1.409A-1(h), without regard to any alternative definition thereunder, a “Separation from Service”), then Executive shall be entitled to receive the Accrued Obligations (as
defined below) and, subject to Executive’s compliance with the obligations in Section 6.1(c) below, Executive shall be eligible to receive the following severance benefits (the “Severance Benefits”): 

  
 3 

 (i) The Company will pay Executive an amount equal to Executive’s then current
Base Salary for nine (9) months, less all applicable withholdings and deductions, and paid in equal installments beginning on the Company’s second regularly scheduled payroll date following the Release Effective Date (as defined in
Section 6.1(c) below), with the remaining installments occurring on the Company’s regularly scheduled payroll dates thereafter. 

(ii) If Executive timely elects continued coverage under COBRA for Executive and Executive’s dependents under the Company’s
group health plans following such termination, then the Company shall pay the COBRA premiums necessary to continue Executive’s and his covered dependents’ health insurance coverage in effect for Executive (and Executive’s covered
dependents) on the termination date until the earliest of: (i) twelve (12) months following the termination date (the “COBRA Severance Period”); (ii) the date when Executive becomes eligible for substantially equivalent
health insurance coverage in connection with new employment or self-employment; or (iii) the date Executive ceases to be eligible for COBRA continuation coverage for any reason, including plan termination (such period from the termination date
through the earlier of (i)-(iii), (the “COBRA Payment Period”). Notwithstanding the foregoing, if at any time the Company determines that its payment of COBRA premiums on Executive’s behalf would result in a violation of
applicable law (including, but not limited to, the 2010 Patient Protection and Affordable Care Act, as amended by the 2010 Health Care and Education Reconciliation Act), then in lieu of paying COBRA premiums pursuant to this Section, the Company
shall pay Executive on the last day of each remaining month of the COBRA Payment Period, a fully taxable cash payment equal to the COBRA premium for such month, subject to applicable tax withholding, for the remainder of the COBRA Payment Period.
Nothing in this Agreement shall deprive Executive of his rights under COBRA or ERISA for benefits under plans and policies arising under his employment by the Company. 

(c) Executive will be paid all of the Accrued Obligations (as defined in Section 6.1(d) below) on the Company’s first
payroll date after Executive’s date of termination from employment or earlier if required by law. If eligible to receive the Severance Benefits pursuant to Section 6.1(b) of this Agreement, Executive will only receive such Severance
Benefits if: (i) within the time period provided in the separation agreement (which shall be no longer than 60 days following the date of Executive’s Separation from Service), Executive has signed and delivered to the Company a separation
agreement that includes, among other terms, an effective general release of claims in favor of the Company and its affiliates and representatives, in the form presented by the Company (the “Release”), which cannot be revoked
in whole or part by such date (the date that the Release can no longer be revoked is referred to as the “Release Effective Date”); and (ii) if Executive holds any other positions with the Company, he resigns such
position(s) to be effective no later than the date of Executive’s termination date (or such other date as requested by the Board); (iii) Executive returns all Company property; (iv) Executive complies with his post- termination obligations
under this Agreement and the Confidential Information Agreement; and (v) Executive complies with the terms of the Release, including, without limitation, any non- disparagement, confidentiality and
cooperation provisions contained in Release. 

  
 4 

 (d) For purposes of this Agreement, “Accrued Obligations”
are (i) Executive’s accrued but unpaid salary through the date of termination, (ii) any unreimbursed business expenses incurred by Executive payable in accordance with the Company’s standard expense reimbursement policies, and
(iii) benefits owed to Executive under any qualified retirement plan or health and welfare benefit plan in which Executive was a participant in accordance with applicable law and the provisions of such plan. 

(e) The Severance Benefits provided to Executive pursuant to this Section 6.1 are in lieu of, and not in addition to, any
benefits to which Executive may otherwise be entitled under any Company severance plan, policy or program. 
 (f) Any damages caused
by the termination of Executive’s employment without Cause would be difficult to ascertain; therefore, the Severance Benefits for which Executive is eligible pursuant to Section 6.1(b) above in exchange for the Release is agreed to by the
parties as liquidated damages, to serve as full compensation, and not a penalty. 
 (g) “Good Reason” for
purposes of this Agreement shall mean the occurrence of any of the following conditions without Executive’s consent, after Executive’s provision of written notice to the Company of the existence of such condition (which notice must be
provided as described in Section 7.1 within thirty (30) days of the initial existence of the condition and must specify the particular condition in reasonable detail), provided that the Company has not first provided notice to Executive of
its intent to terminate Executive’s employment: (i) a material reduction in Executive’s duties, responsibilities or authorities, provided, however, that neither the conversation of the Company to a subsidiary, division or unit of an
acquiring entity, or Executive’s reporting relationships following a Change in Control, nor a change in title, will be deemed a “material reduction” in and of itself or material adverse alteration in, Executive’s position, title,
duties, or responsibilities; (ii) a material (greater than 10%) reduction by the Company of Executive’s Base Salary (except in the case of either an across the board reduction in salaries or a temporary reduction due to financial
exigency); or (iii) the relocation of Executive’s principal place of employment by fifty (50) or more miles from Executive’s then- current principal place of employment. Notwithstanding the foregoing, Good Reason shall only exist
if the Company is provided a thirty (30) day period to cure the event or condition giving rise to Good Reason, and it fails to do so within that cure period (and, additionally, Executive must resign for such Good Reason condition by giving
notice as described in Section 7.1 within thirty (30) days after the period for curing the violation or condition has ended). 

6.2 Termination by the Company for Cause. 

(a) The Company shall have the right to terminate Executive’s employment with the Company at any time for Cause by giving notice
as described in Section 7.1 of this Agreement. 
 (b) “Cause” for purposes of this Agreement shall mean
that the Company has determined in its sole discretion that Executive has engaged in any of the following: (i) a material breach of any covenant or condition under this Agreement or any other agreement between the Company and Executive;
(ii) any act constituting dishonesty, fraud, immoral or disreputable conduct; (iii) any conduct which constitutes a felony under applicable law; 

  
 5 

 
(iv) violation of any Company policy or any act of misconduct; (v) refusal to follow or implement a clear and reasonable directive of Company; (vi) negligence or incompetence in the
performance of Executive’s duties or failure to perform such duties in a manner satisfactory to the Company after the expiration of ten (10) days without cure after written notice of such failure; (vii) failure to pass to the
satisfaction of the Company, a preliminary background check or failure to submit proof of legal eligibility to work in the United States; or (viii) breach of fiduciary duty. 

(c) In the event Executive’s employment is terminated at any time for Cause, Executive will not receive Severance Benefits, or
any other compensation or benefits, except that, pursuant to the Company’s standard payroll policies, the Company shall provide to Executive the Accrued Obligations. 

6.3 Resignation by Executive (other than for Good Reason). 

(a) Executive may resign from Executive’s employment with the Company at any time by giving notice as described in
Section 7.1. 
 (b) In the event Executive resigns from Executive’s employment with the Company (other than for Good
Reason), Executive will not receive Severance Benefits, or any other compensation or benefits, except that, pursuant to the Company’s standard payroll policies, the Company shall provide to Executive the Accrued Obligations. 

6.4 Termination by Virtue of Death or Disability of Executive. 

(a) In the event of Executive’s death while employed pursuant to this Agreement, all obligations of the parties hereunder shall
terminate immediately, and the Company shall, pursuant to the Company’s standard payroll policies, provide to Executive’s legal representatives Executive’s accrued but unpaid salary through the date of death together with all
compensation and benefits payable to Executive based on his participation in any compensation or benefit plan, program or arrangement through the date of termination. 

(b) Subject to applicable state and federal law, the Company shall at all times have the right, upon written notice to Executive, to
terminate this Agreement based on Executive’s Disability (as defined below). Termination by the Company of Executive’s employment based on “Disability” shall mean termination because Executive is unable due to a
physical or mental condition to perform the essential functions of Executive’s position with or without reasonable accommodation for one hundred twenty (120) consecutive calendar days or six (6) months in the aggregate during any
twelve (12) month period or based on the written certification by two licensed physicians of the likely continuation of such condition for such period. This definition shall be interpreted and applied consistent with the Americans with
Disabilities Act, the Family and Medical Leave Act, and other applicable law. In the event Executive’s employment is terminated based on Executive’s Disability, Executive will not receive the Severance Benefits, or any other severance
compensation or benefit, except that, pursuant to the Company’s standard payroll policies, the Company shall pay to Executive the accrued but unpaid salary of Executive through the date of termination, together with all compensation and
benefits payable to Executive based on his participation in any compensation or benefit plan, program or arrangement through the date of termination. 

  
 6 

 6.5 [RESERVED] 

6.6 Notice; Effective Date of Termination. 

(a) Termination of Executive’s employment pursuant to this Agreement shall be effective on the earliest of: 

(i) immediately after the Company gives notice to Executive of Executive’s termination, with or without Cause, unless pursuant to
Section 6.2(b)(vi) in which case ten (10) days after notice if not cured or unless the Company specifies a later date, in which case, termination shall be effective as of such later date; 

(ii) immediately upon Executive’s death; 

(iii) ten (10) days after the Company gives notice to Executive of Executive’s termination on account of Executive’s
Disability, unless the Company specifies a later date, in which case, termination shall be effective as of such later date, provided that Executive has not returned to the full time performance of Executive’s duties prior to such date; 

(iv) ten (10) days after Executive gives written notice to the Company of Executive’s resignation, provided that the Company
may set a termination date at any time between the date of notice and the date of resignation, in which case Executive’s resignation shall be effective as of such other date. Executive will receive compensation through any required notice
period; or 
 (v) for a termination for Good Reason, immediately upon Executive’s full satisfaction of the requirements of
Section 6.1(g). 
 (b) In the event notice of a termination under subsections (a)(i) and (iii) is given orally, at the
other party’s request, the party giving notice must provide written confirmation of such notice within five (5) business days of the request in compliance with the requirement of Section 7.1 below. In the event of a termination for
Cause, written confirmation shall specify the subsection(s) of the definition of Cause relied on to support the decision to terminate. 

6.7 Cooperation With Company After Termination of Employment. Following termination of Executive’s employment for
any reason, Executive shall fully cooperate with the Company in all matters relating to the winding up of Executive’s pending work including, but not limited to, any litigation in which the Company is involved, and the orderly transfer of any
such pending work to such other employees as may be designated by the Company. The Company will reimburse Executive for reasonable out-of-pocket expenses Executive
incurs in connection with any such cooperation (excluding forgone wages, salary, or other compensation) and will make reasonable efforts to accommodate Executive’s scheduling needs. 

6.8 Application of Section 409A. It is intended that all of the benefits and payments
under this Agreement satisfy, to the greatest extent possible, the exemptions from the application of Section 409A of the Code provided under Treasury Regulations 1.409A-1(b)(4),

  
 7 

 
1.409A-1(b)(5) and 1.409A-1(b)(9), and this Agreement will be construed to the greatest extent possible as
consistent with those provisions. If not so exempt, this Agreement (and any definitions hereunder) will be construed in a manner that complies with Section 409A of the Code, and incorporates by reference all required definitions and payment
terms. For purposes of Section 409A of the Code (including, without limitation, for purposes of Treasury Regulation Section 1.409A-2(b)(2)(iii)), Executive’s right to receive any installment
payments under this Agreement (whether severance payments, reimbursements or otherwise) will be treated as a right to receive a series of separate payments and, accordingly, each installment payment hereunder will at all times be considered a
separate and distinct payment. Notwithstanding any provision to the contrary in this Agreement, if Executive is deemed by the Company at the time of his Separation from Service to be a “specified employee” for purposes of
Section 409A(a)(2)(B)(i) of the Code, and if any of the payments upon Separation from Service set forth herein and/or under any other agreement with the Company are deemed to be “deferred compensation”, then if delayed commencement of
any portion of such payments is required to avoid a prohibited distribution under Section 409A(a)(2)(B)(i) of the Code and the related adverse taxation under Section 409A of the Code, the timing of the payments upon a Separation from
Service will be delayed as follows: on the earlier to occur of (i) the date that is six months and one day after the effective date of Executive’s Separation from Service, and (ii) the date of Executive’s death (such earlier
date, the “Delayed Initial Payment Date”), the Company will (A) pay to Executive a lump sum amount equal to the sum of the payments upon Separation from Service that Executive would otherwise have received through the
Delayed Initial Payment Date if the commencement of the payments had not been delayed pursuant to this paragraph, and (B) commence paying the balance of the payments in accordance with the applicable payment schedules set forth above. No
interest will be due on any amounts so deferred. 
 7. GENERAL
PROVISIONS. 
 7.1 Notices. Any notices required hereunder to be
in writing shall be deemed effectively given: (a) upon personal delivery to the party to be notified, (b) when sent by electronic mail or confirmed facsimile if sent during normal business hours of the recipient, and if not, then on the
next business day, (c) five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one (1) day after deposit with a nationally recognized overnight courier, specifying next day
delivery, with written verification of receipt. All communications shall be sent to the Company at its primary office location and to Executive at Executive’s address as listed on the Company payroll or to Executive’s Company-issued email
address or Executive’s email address as listed in Company records, or at such other address as the Company or Executive may designate by ten (10) days advance written notice to the other. 

7.2 Severability. Whenever possible, each provision of this Agreement will be interpreted in such manner as to be
effective and valid under applicable law, but if any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability
will not affect any other provision or any other jurisdiction, but this Agreement will be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provisions had never been contained herein. 

  
 8 

 7.3 Survival. Provisions of this Agreement which by their terms must
survive the termination of this Agreement in order to effectuate the intent of the parties will survive any such termination, whether by expiration of the term, termination of Executive’s employment, or otherwise, for such period as may be
appropriate under the circumstances. 
 7.4 Waiver. If either party should waive any breach of any provisions of this
Agreement, it shall not thereby be deemed to have waived any preceding or succeeding breach of the same or any other provision of this Agreement. 

7.5 Complete Agreement. This Agreement constitutes the entire agreement between Executive and the Company with regard to
the subject matter hereof. This Agreement is the complete, final, and exclusive embodiment of their agreement with regard to this subject matter and supersedes any prior oral discussions or written communications and agreements. This Agreement is
entered into without reliance on any promise or representation other than those expressly contained herein, and it cannot be modified or amended except in writing signed by Executive and an authorized officer of the Company. The parties have entered
into a separate Confidential Information Agreement and have or may enter into separate agreements related to equity. These separate agreements govern other aspects of the relationship between the parties, have or may have provisions that survive
termination of Executive’s employment under this Agreement, may be amended or superseded by the parties without regard to this Agreement and are enforceable according to their terms without regard to the enforcement provision of this Agreement.

 7.6 Counterparts. This Agreement may be executed in separate counterparts, any one of which need not contain
signatures of more than one party, but all of which taken together will constitute one and the same Agreement. 
 7.7
Headings. The headings of the sections hereof are inserted for convenience only and shall not be deemed to constitute a part hereof nor to affect the meaning thereof. 

7.8 Successors and Assigns. The Company shall assign this Agreement and its rights and obligations hereunder in whole,
but not in part, to any Company or other entity with or into which the Company may hereafter merge or consolidate or to which the Company may transfer all or substantially all of its assets, if in any such case said Company or other entity shall by
operation of law or expressly in writing assume all obligations of the Company hereunder as fully as if it had been originally made a party hereto, but may not otherwise assign this Agreement or its rights and obligations hereunder. Executive may
not assign or transfer this Agreement or any rights or obligations hereunder, other than to Executive’s estate upon Executive’s death. 

7.9 Choice of Law. All questions concerning the construction, validity and interpretation of this Agreement will be
governed by the law of the Commonwealth of Virginia. 
 7.10 Resolution of Disputes. The parties recognize that
litigation in federal or state courts or before federal or state administrative agencies of disputes arising out of Executive’s employment with the Company or out of this Agreement, or Executive’s termination of employment or termination
of this Agreement, may not be in the best interests of either Executive or the Company, and may result in unnecessary costs, delays, complexities, and uncertainty. The 

  
 9 

 
parties agree that any dispute between the parties arising out of or relating to the negotiation, execution, performance or termination of this Agreement or Executive’s employment,
including, but not limited to, any claim arising out of this Agreement, claims under Title VII of the Civil Rights Act of 1964, as amended, the Civil Rights Act of 1991, the Age Discrimination in Employment Act of 1967, the Americans with
Disabilities Act of 1990, Section 1981 of the Civil Rights Act of 1966, as amended, the Family Medical Leave Act, the Executive Retirement Income Security Act, and any similar federal, state or local law, statute, regulation, or any common law
doctrine, whether that dispute arises during or after employment, shall be settled by binding arbitration in accordance with the Employment Arbitration Rules and Mediation Procedures of the American Arbitration Association; provided however, that
this dispute resolution provision shall not apply to any separate agreements between the parties that do not themselves specify arbitration as an exclusive remedy. The location for the arbitration shall be the Charlottesville, Virginia area. Any
award made by such panel shall be final, binding and conclusive on the parties for all purposes, and judgment upon the award rendered by the arbitrators may be entered in any court having jurisdiction thereof. The arbitrators’ fees and expenses
and all administrative fees and expenses associated with the filing of the arbitration shall be borne by the Company; provided however, that at Executive’s option, Executive may voluntarily pay up to
one-half the costs and fees. The parties acknowledge and agree that their obligations to arbitrate under this Section survive the termination of this Agreement and continue after the termination of the
employment relationship between Executive and the Company. The parties each further agree that the arbitration provisions of this Agreement shall provide each party with its exclusive remedy, and each party expressly waives any right it might
have to seek redress in any other forum, except as otherwise expressly provided in this Agreement. By election arbitration as the means for final settlement of all claims, the parties hereby waive their respective rights to, and agree not to, sue
each other in any action in a Federal, State or local court with respect to such claims, but may seek to enforce in court an arbitration award rendered pursuant to this Agreement. The parties specifically agree to waive their respective rights to a
trial by jury, and further agree that no demand, request or motion will be made for trial by jury. 
 SIGNATURE PAGE FOLLOWS 

  
 10 

 IN WITNESS WHEREOF, the parties have
executed this Employment Agreement on the day and year written below effective as of the Effective Date (as defined herein). 
  

			
	Acumen Pharmaceuticals, Inc.
		
	By:	 	/s/ Daniel J. O’Connell
	 	 	Daniel J. O’Connell,
	 	 	President and Chief Executive Officer
	
	Executive:
	
	/s/ William Matthew Zuga
	Wm. Matthew Zuga
	
	5/15/2021
	DateEXHIBIT 10.1

 

Employment Agreement

 

This
Employment Agreement (the “Agreement”)
is made and entered into as of August 11, 2021 (the “Execution
Date”), by and between MARK DYBUL (the “Executive”)
and ENOCHIAN BIOSCIENCES, INC., a Delaware corporation (the “Company”).

 

WHEREAS, the Company desires to
employ the Executive on the terms and conditions set forth herein;

 

WHEREAS, the Executive desires
to be employed by the Company on such terms and conditions; and

 

WHEREAS, each of the Executive
and the Company desire to terminate, with and upon the execution of this Agreement, that certain Amended and Restated Director Agreement
made between the Executive and the Company on November 21, 2018.

 

NOW, THEREFORE, in consideration
of the mutual covenants, promises, and obligations set forth herein, the parties agree as follows:

 

1.             
Term.
The Executive’s employment hereunder shall be effective as of July 1, 2021 or such earlier
date as shall be agreed to by the Executive and the Company (the “Effective
Date”), and shall continue until the third (3rd) anniversary
thereof, unless terminated earlier pursuant to Section 5 of this Agreement; provided that, on such third (3rd) anniversary and each annual
anniversary thereafter (such date and each annual anniversary thereof, a “Renewal
Date”), the Agreement shall be deemed to be automatically
extended for successive periods of one year, unless either party provides written notice of its intention not to extend the term of the
Agreement at least ninety (90) days’ prior to the applicable
Renewal Date. The period during which the Executive is employed by the Company hereunder is hereinafter referred to as the “Term”.

 

2.             
Position
and Duties.

 

2.1               
Position.
During the Term, the Executive shall serve as the Chief Executive Officer of the Company, reporting to the Board of Directors (the “Board”).
In such position, the Executive shall have such duties, authority, and responsibility as shall be determined from time to time by the
Board or its designee, which duties, authority, and responsibility are consistent with the Executive’s
position. The Executive shall also serve as a member of the Board, but as of the Effective Date and continuing while this Agreement is
in effect, the Executive shall receive no further compensation pursuant to that certain Amended and Restated Director Agreement, as amended,
between the Executive and the Company (the “Director
Agreement”) for such service.

 

2.2               
Duties.
During the Term, the Executive shall devote a substantial majority of the Executive’s business
time and attention to the performance of the Executive’s
duties hereunder and will not engage in any other business, profession, or occupation for compensation or otherwise which would conflict
or interfere with the performance of such services either directly or indirectly without the prior written consent of the Board. Notwithstanding
the foregoing, the Executive will be permitted to (a) with the prior written consent of the Board, which consent will not be unreasonably
withheld or delayed, act or serve as a director, trustee, committee member, or principal of any type of civic or charitable organization
as long as such activities are disclosed in writing to the Company, (b) purchase or own less than five percent (5%) of the publicly traded
securities of any corporation unaffiliated with the Company, provided that, such ownership represents a passive investment and that the
Executive is not a controlling person of, or a member of a group that controls, such corporation, (c) serve on up to five (5) boards of
directors or advisory boards (or other governing bodies) of non-competitive corporations (or other entities) and (d) own membership interests
and participate in the operations of Weird Science, LLC; provided however that, the activities described in clauses (a), (b), (c) and
(d) do not materially interfere with the performance of the Executive’s
duties and responsibilities to the Company as provided hereunder.

 

     

     

    

 

2.3               
Compliance with Rules and Policies. The Executive shall
perform all services in accordance with the policies, procedures and rules established by the Company and the Board. In addition, the
Executive shall comply with all laws, rules and regulations that are generally applicable to the Company or its affiliates and their respective
employees, directors and officers.

 

3.             
Place
of Performance. The principal place of Executive’s
employment shall be Los Angeles, California, provided that, the Company acknowledges that the Executive shall continue to reside outside
of Los Angeles, and shall commute to Los Angeles as reasonably required during the Term.

 

4.             
Compensation.

 

4.1               
Base
Salary. The Company shall pay the Executive an annual rate of base salary of Eight Hundred Fifty
Thousand Dollars ($850,000) (the “Base Salary”)
in periodic installments in accordance with the Company’s
customary payroll practices and applicable wage payment laws, but no less frequently than monthly. The Executive’s
Base Salary shall be reviewed at least annually by the Board and the Board may, but shall not be required to, increase the Base Salary
during the Term. 

 

4.2               
Variable
Compensation. The Executive shall be eligible for additional compensation of up to 60% of the
Base Salary per year in the sole discretion of the Company’s
Compensation Committee (the “Variable Compensation”),
subject to any additional terms and conditions that may be adopted by the Company’s
Compensation Committee from time to time and in accordance with any Short Term Incentive Plan that
may be adopted by the Company. In order
to be eligible to receive the Variable Compensation, the Executive must be employed by the Company in good standing at the time of payment.
The Company will evaluate and determine the Variable Compensation offered each year based
on a combination of Company results and individual performance against the actual performance goals established by the Company, subject
to the approval of the Board’s Compensation Committee. The Board or a duly
authorized committee thereof, in its discretion, may elect to amend and/or discontinue the Variable Compensation offered to the Executive,
provided that the Company does so based on a reasonable, good faith assessment of the performance of the Executive and/or the Company.

 

4.3               
Options.
The Executive shall be eligible to receive options to purchase Three Million (3,000,000) shares
of Company’s common stock (the “Options”). Options for One Million
(1,000,000) shares shall vest upon the achievement of certain performance metrics to be set
forth in an option award agreement between the Executive and the Company. Except
as set forth in Section 5.2, the remaining Options covering Two Million (2,000,000) shares (the “Time
Vesting Options”) shall vest in three equal annual installments on the first, second and
third anniversaries of the Effective Date; provided, however, that all vesting is subject to the Executive’s continued employment
status through each vesting date; provided further, that following the Effective Date, all unvested Options shall immediately vest upon
a Change in Control, as defined below.

 

4.4               
Employee
Benefits. During the Term, the Executive shall be entitled to participate in all employee benefit
plans, practices, and programs maintained by the Company, as in effect from time to time (collectively, “Employee
Benefit Plans”), on a basis which is no less favorable
than is provided to other similarly situated executives of the Company, to the extent consistent with applicable law and the terms of
the applicable Employee Benefit Plans. The Company reserves the right to amend or cancel any Employee Benefit Plans at any time in its
sole discretion, subject to the terms of such Employee Benefit Plans and applicable law.

 

4.5               
Vacation. During the Term, the Executive shall be entitled to five (5) weeks’
vacation per year in accordance with the Company’s
vacation policies, as in effect from time to time. 

 

4.6               
Business
Expenses. The Executive shall be entitled to reimbursement for all reasonable and necessary out-of-pocket
business, entertainment, and travel expenses incurred by the Executive in connection with the performance of the Executive’s
duties hereunder in accordance with the Company’s expense
reimbursement policies and procedures.

 

    2 

     

    

 

4.7               
Rental
Accommodations. The Company will provide access to a corporate apartment as appropriate, or at
the Executive’s option, will reimburse the Executive for reasonable expenses for accommodations
in Los Angeles, California, and the Company will also provide a company car, each to be selected by the Executive and reasonably acceptable
to the Company.

 

5.             
Termination
of Employment. Upon termination of the Executive’s
employment during the Term, the Executive shall be entitled to the compensation and benefits described in this Section 5 and shall have
no further rights to any compensation or any other benefits from the Company or any of its affiliates. The last day in which the Executive
is an employee of the Company shall be the “Termination
Date.”

 

5.1               
Expiration
of the Term, for Cause or Without Good Reason.

 

(a)                
The Executive’s employment hereunder may be terminated
upon expiration of the Agreement in accordance with Section 1, by the Company for Cause or by the Executive without Good Reason. If the
Executive’s employment is terminated upon expiration of
the Agreement, by the Company for Cause or by the Executive without Good Reason, the Executive shall be entitled to receive:

 

(i)                 
any accrued but unpaid Base Salary and accrued but unused vacation which shall be paid on the Termination
Date (as defined below); 

 

(ii)               
reimbursement for unreimbursed business expenses properly incurred by the Executive, which shall
be subject to and paid in accordance with the Company’s expense reimbursement policy; 

 

(iii)             
such employee benefits, if any, to which the Executive may be entitled under the Company’s
employee benefit plans and vested as of the Termination Date, provided that, in no event shall the Executive be entitled to any payments
or benefits in the nature of severance or termination payments or benefits except as specifically provided herein; and 

 

(iv)              
any vested Options.

 

Items
5.1(a)(i) through 5.1(a)(iv) are referred to herein collectively as the “Accrued Amounts”.

 

(b)               
For purposes of this Agreement, “Cause”
shall mean:

 

(i)                 
the Executive’s willful failure to materially perform
his duties (other than any such failure resulting from incapacity due to physical or mental illness);

 

(ii)               
the Executive’s willful failure to comply with any valid
and legal directive of the Board;

 

(iii)             
the Executive’s engagement in dishonesty, illegal conduct
or gross misconduct;

 

(iv)              
the Executive’s embezzlement, misappropriation, or fraud,
whether or not related to the Executive’s employment with
the Company;

 

    3 

     

    

 

(v)               
the Executive’s conviction of or plea of guilty or nolo
contendere to a crime that constitutes a felony (or state law equivalent) or any crime involving moral turpitude;

 

(vi)              
the Executive’s willful unauthorized disclosure of Confidential
Information (as defined in the Confidentiality and Proprietary Information Agreement attached hereto as Addendum A);

 

(vii)            
the Executive’s breach of any material obligation under
this Agreement or any other written agreement between the Executive and the Company; or

 

(viii)          
The Executive’s violation or material failure by the Executive
to comply with the Company’s written policies or rules,
as they may be in effect from time to time during the Term.

 

The
Company cannot terminate the Executive’s employment for Cause pursuant to subsections 5.1(b)
(i), (ii), (vi), (vii) and/or (viii) unless the Company has provided written notice to the Executive of the existence of any of the conditions
set forth above providing grounds for termination for Cause within thirty (30) days of the initial existence of such condition(s) and
the Executive has had at least sixty (60) days from the date on which such notice is provided to cure such condition(s) (the “Company
Cure Period”). 

 

(c)                
For purposes of this Agreement, “Good Reason”
shall mean the occurrence of any of the following conditions, in each case during the Term without the Executive’s
written consent:

 

(i)                 
a material reduction in the Executive’s Base Salary other
than a general reduction in Base Salary that affects all similarly situated executives in substantially the same proportion;

 

(ii)               
any breach by the Company of any material provision of this Agreement or any other agreement between
the Executive and the Company;

 

(iii)             
a Change in Control, as defined below; or

 

(iv)              
a material, adverse change in the Executive’s authority,
duties, or responsibilities (other than temporarily while the Executive is physically or mentally incapacitated or as required by applicable
law); provided, however, that a reduction in the Executive’s
authority, duties or responsibilities solely by virtue of the Company being acquired and made part of a division or subsidiary of the
acquirer that contains the Company’s business, and in
which the Executive has a comparable position with comparable terms and conditions of employment to this Agreement, shall not constitute
a Good Reason.

 

The
Executive cannot terminate his employment for Good Reason unless the Executive has provided written notice to the Company of the existence
of any of the conditions set forth above providing grounds for termination for Good Reason within thirty (30) days of the initial existence
of such condition(s) and the Company has had at least thirty (30) days from the date on which such notice is provided to cure such condition(s)
(the “Executive Cure Period”).
If the Executive does not terminate his employment for Good Reason within ten (10) business days after the earlier of the end of the Executive
Cure Period or the date the Company provides notice to the Executive during the Executive Cure Period that the Company will not cure the
condition(s) that the Executive provided in his written notice, then the Executive will be deemed to have waived his right to terminate
for Good Reason with respect to such grounds.

 

For
purposes of this Section 5.1(c), “Change of Control”
shall mean the consummation in a single transaction or in a series
of related transactions, of any one or more of the following events:

 

    4 

     

    

 

(i)       a
sale, transfer or disposition of all or substantially all of the Company’s assets other than
to an “Excluded Entity,”
which may be one of the following: (A) a corporation or other entity of which at least a majority of
its combined voting power is owned directly or indirectly by the Company, (B) a corporation or other entity owned directly or indirectly
by the holders of capital stock of the Company in substantially the same proportions as their ownership of the Company’s
common stock, or (C) another corporation, entity or person in which the holders of at least a majority of the shares of voting capital
stock of the Company outstanding immediately prior to such transaction continue to hold (either by such shares remaining outstanding in
the continuing entity or by their being converted into shares of voting capital stock of the surviving entity) a majority of the total
voting power represented by the shares of voting capital stock of the Company (or the surviving entity) outstanding immediately after
such transaction; 

 

(ii) any merger, consolidation
or other business combination transaction of the Company with or into another corporation, entity or person, other than a transaction
with or into an Excluded Entity;

 

(iii) any
“person” (as
such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”)) becomes the “beneficial
owner” (as defined in Rule 13d-3 of the Exchange Act),
directly or indirectly, of securities of the Company representing more than fifty percent (50%) of the combined voting power
of the Company’s then outstanding securities other than
by virtue of a merger, consolidation or similar transaction. Notwithstanding the foregoing, a Change of Control shall not be deemed to
occur under this subsection (iii), as follows: (A) on account of the acquisition of securities of the Company directly from the Company,
(B) on account of the acquisition of securities of the Company by any person that acquires the Company’s
securities in a transaction or series of related transactions the primary purpose of which is to obtain financing for the Company through
the issuance of equity securities or (C) solely because the level of beneficial ownership held by any person exceeds the designated
percentage threshold of the outstanding voting securities as a result of a repurchase or other acquisition of voting securities by the
Company reducing the number of shares outstanding, provided that if a Change of Control would occur (but for the operation of this sentence)
as a result of the acquisition of voting securities by the Company, and after such share acquisition, such person becomes the beneficial
owner of any additional voting securities that, assuming the repurchase or other acquisition had not occurred, increases the percentage
of the then outstanding voting securities beneficially owned by such person over the designated percentage threshold, then a Change of
Control shall be deemed to occur.

 

Notwithstanding
the foregoing, the following transactions shall not constitute a Change of Control: (A) if its purpose is to change the jurisdiction of
the Company’s incorporation, (B) if its purpose is to create a holding company that will be
owned in substantially the same proportions by the persons who hold the Company’s
securities immediately before such transaction, (C) if its purpose is to obtain funding for the Company in a financing that is approved
by the Company’s Board, (D) if it is solely the result
of the increase of the holdings of an existing shareholder resulting in such existing major shareholder owning a majority of the voting
power of the Company without any merger, consolidation or other business combination transaction or (E) if the Board determines in good
faith that the transaction does not constitute a Change of Control for purposes of this Agreement.

 

    5 

     

    

 

5.2               
Involuntary
Termination Without Cause or Voluntary Termination for Good Reason. This Agreement and the Executive’s
employment hereunder may be involuntarily terminated by the Company without Cause, or voluntarily terminated by the Executive for Good
Reason, and in either case notwithstanding anything to the contrary in this Agreement, the Executive shall be entitled to receive the
Accrued Amounts; and subject to the Executive signing and not revoking a release of claims in the
form that the Company generally uses in connection with such involuntary termination (the “Release”),
the Executive shall receive (a) continued Base Salary for twelve (12) months from the Termination Date, or the date on which the Executive
obtains comparable, alternate employment, whichever is earlier, payable in equal installments in accordance with the Company’s
normal payroll practices, but no less frequently than monthly, which shall commence on the next payroll date following the Termination
Date; provided that, if the period of time in which the Executive has to consider and revoke the Release (the “Release
Execution Period”) begins in one taxable year and
ends in another taxable year, payments shall not begin until the later of the first payroll date after January 1 of the year following
the Termination Date or after the Release becomes effective upon its terms; provided further that, the first installment payment shall
include all amounts of Base Salary that would otherwise have been paid to the Executive during the period beginning on the Termination
Date and ending on the first payment date if no delay had been imposed; (b) the vesting of one third (1/3) of the Time Vesting Options
in the event that a portion of such Time Vesting Options remains unvested; (c) a pro rata portion of the variable compensation in Section
4.2; and (d) payment of Executive’s COBRA premiums, and
any administrative fees, for a period of 12 months after Executive’s
Termination Date if Executive timely elects COBRA coverage. 

 

5.3               
Death
or Disability. The Executive’s employment hereunder
shall terminate automatically upon the Executive’s death
during the Term, and the Company may terminate the Executive’s
employment on account of the Executive’s Disability. 

 

(a)                
If the Executive’s employment is terminated during the
Term on account of the Executive’s death or Disability,
the Executive (or the Executive’s estate and/or beneficiaries,
as the case may be) shall be entitled to receive the Accrued Amounts. 

 

(b)               
Notwithstanding any other provision contained herein, all payments made in connection with the Executive’s
Disability shall be provided in a manner which is consistent with federal and state law.

 

(c)                
For purposes of this Agreement, “Disability”
shall mean the Executive is eligible to receive disability insurance
under the Company’s voluntary long-term disability program.

 

5.4               
Resignation
of All Other Positions. Upon termination of the Executive’s
employment hereunder for any reason, the Executive agrees to resign, effective on the Termination Date and shall be deemed to have resigned
from all positions that the Executive holds as an officer or member of the Board (or a committee thereof) of the Company or any of its
affiliates. The Executive also agrees to relinquish any power of attorney, signing authority, trust
authorization or bank account signatory authorization that the Executive may hold on behalf of the Company or any of its affiliates.

 

6.             
Cooperation.
The parties agree that certain matters in which the Executive will be involved during the Term may necessitate the Executive’s
cooperation in the future. Accordingly, following the termination of the Executive’s
employment for any reason, to the extent reasonably requested by the Board, the Executive shall cooperate with the Company in connection
with matters arising out of the Executive’s service to
the Company; provided that, the Company shall make reasonable efforts to minimize disruption of the Executive’s
other activities. The Company shall reimburse the Executive for reasonable expenses incurred in connection with such cooperation.

 

7.             
Confidential
and
Propriety Rights. The Executive will comply with all terms of the Confidential and Proprietary
Information Agreement, attached hereto as Addendum A and incorporated herein by reference, as a material condition of this Agreement.

 

8.             
Arbitration.
To the extent permitted by applicable law, the parties shall arbitrate disputes in accordance with the terms of the Arbitration Agreement
attached hereto as Addendum B and incorporated herein by reference.

 

    6 

     

    

 

9.             
Security.

 

9.1               
Security
and Access. The Executive agrees and covenants (a) to comply with all Company security policies
and procedures as in force from time to time, including without limitation those regarding computer equipment, telephone systems, voicemail
systems, facilities access, monitoring, key cards, access codes, Company intranet, internet, social media and instant messaging systems,
computer systems, e-mail systems, computer networks, document storage systems, software, data security, encryption, firewalls, passwords
and any and all other Company facilities, IT resources and communication technologies (“Facilities
and Information Technology Resources”); (b) not to
access or use any Facilities and Information Technology Resources except as authorized by the Company; and (c) not to access or use any
Facilities and Information Technology Resources in any manner after the termination of the Executive’s
employment by the Company, whether termination is voluntary or involuntary. The Executive agrees to notify the Company promptly in the
event he learns of any violation of the foregoing by others, or of any other misappropriation or unauthorized access, use, reproduction,
or reverse engineering of, or tampering with any Facilities and Information Technology Resources or other Company property or materials
by others. 

 

9.2               
Exit
Obligations. Upon a voluntary or involuntary termination of the Executive’s
employment or the Company’s request at any time during
the Executive’s employment, the Executive shall (a) provide
or return to the Company any and all Company property, including keys, key cards, access cards, identification cards, security devices,
employer credit cards, network access devices, computers, cell phones, smartphones, PDAs, pagers, fax machines, equipment, speakers, webcams,
manuals, reports, files, books, compilations, work product, e-mail messages, recordings, tapes, disks, thumb drives or other removable
information storage devices, hard drives, negatives and data and all Company documents and materials belonging to the Company and stored
in any fashion, including but not limited to those that constitute or contain any Confidential Information or Work Product, that are in
the possession or control of the Executive, whether they were provided to the Executive by the Company or any of its business associates
or created by the Executive in connection with his employment by the Company; (b) delete or destroy all copies of any such documents and
materials not returned to the Company that remain in the Executive’s
possession or control, including those stored on any non-Company devices, networks, storage locations, and media in the Executive’s
possession or control and, upon request by the Company, submit an affidavit attesting to such deletion or destruction; (c) produce for
inspection any laptops, tablets or other mobile devices that the Executive has used for work-related purposes and permit the Company to
delete all Company data from such devices; and (d) disclose to the Company all passwords and passcodes in the Executive’s
knowledge and/or possession relating to the Company’s
operations.

 

10.          
Governing
Law: Jurisdiction and Venue. This Agreement, for all purposes, shall be construed in accordance
with the laws of the State of Delaware without regard to conflicts of law principles.

 

11.          
Entire
Agreement. Unless specifically provided herein, this Agreement contains all of the understandings
and representations between the Executive and the Company pertaining to the subject matter hereof and supersedes all prior and contemporaneous
understandings, agreements, representations and warranties, both written and oral, with respect to such subject matter, including the
Director Agreement. The parties mutually agree that the Agreement can be specifically enforced in court and can be cited as evidence in
legal proceedings alleging breach of the Agreement. 

 

12.          
Modification
and Waiver. No provision of this Agreement may be amended or modified unless such amendment or
modification is agreed to in writing and signed by the Executive and by a specific designee of the Board. No
waiver by either of the parties of any breach by the other party hereto of any condition or provision of this Agreement to be performed
by the other party hereto shall be deemed a waiver of any similar or dissimilar provision or condition at the same or any prior or subsequent
time, nor shall the failure of or delay by either of the parties in exercising any right, power, or privilege hereunder operate as a waiver
thereof to preclude any other or further exercise thereof or the exercise of any other such right, power, or privilege.

 

    7 

     

    

 

13.          
Severability.
Should any provision of this Agreement be held by a court of competent jurisdiction to be enforceable only if modified, or if any portion
of this Agreement shall be held as unenforceable and thus stricken, such holding shall not affect the validity of the remainder of this
Agreement, the balance of which shall continue to be binding upon the parties with any such modification to become a part hereof and treated
as though originally set forth in this Agreement. 

 

The parties further agree that
any such court is expressly authorized to modify any such unenforceable provision of this Agreement in lieu of severing such unenforceable
provision from this Agreement in its entirety, whether by rewriting the offending provision, deleting any or all of the offending provision,
adding additional language to this Agreement, or by making such other modifications as it deems warranted to carry out the intent and
agreement of the parties as embodied herein to the maximum extent permitted by law.

 

The parties expressly agree that
this Agreement as so modified by the court shall be binding upon and enforceable against each of them. In any event, should one or more
of the provisions of this Agreement be held to be invalid, illegal, or unenforceable in any respect, such invalidity, illegality, or unenforceability
shall not affect any other provisions hereof, and if such provision or provisions are not modified as provided above, this Agreement shall
be construed as if such invalid, illegal, or unenforceable provisions had not been set forth herein.

 

14.          
Captions.
Captions and headings of the sections and paragraphs of this Agreement are intended solely for convenience and no provision of this Agreement
is to be construed by reference to the caption or heading of any section or paragraph.

 

15.          
Counterparts.
This Agreement may be executed in separate counterparts, each of which shall be deemed an original, but all of which taken together shall
constitute one and the same instrument.

 

16.          
Tolling.
Should the Executive violate any of the terms of the restrictive covenant obligations articulated herein, the obligation at issue will
run from the first date on which the Executive ceases to be in violation of such obligation.

 

17.          
Section
409A.

 

17.1            
General
Compliance. This Agreement is intended to comply with Section 409A of the Internal Revenue Code
of 1986, as amended, and regulations and guidance promulgated thereunder (“Section 409A”)
or an exemption thereunder and shall be construed and administered in accordance with Section 409A. Notwithstanding any other provision
of this Agreement, payments provided under this Agreement may only be made upon an event and in a manner that complies with Section 409A
or an applicable exemption. Any payments under this Agreement that may be excluded from Section 409A either as separation pay due to an
involuntary separation from service or as a short-term deferral shall be excluded from Section 409A to the maximum extent possible. For
purposes of Section 409A, each installment payment provided under this Agreement shall be treated as a separate payment. Any payments
to be made under this Agreement upon a termination of employment shall only be made upon a “separation
from service” as defined under Section 409A. In the event
that the period for consideration of a release of claims and the revocation period crosses two calendar years, payment under this Agreement
shall be made on the first payroll date in such second calendar year that occurs on or after the expiration of the applicable release
revocation period, regardless of the date the release of claims is signed. Notwithstanding the foregoing, the Company makes no representations
that the payments and benefits provided under this Agreement comply with Section 409A, and in no event shall the Company be liable for
all or any portion of any taxes, penalties, interest, or other expenses that may be incurred by the Executive on account of non-compliance
with Section 409A.

 

    8 

     

    

 

17.2            
Specified
Employees. Notwithstanding any other provision of this Agreement, if any payment or benefit provided
to the Executive in connection with termination of employment is determined to constitute “nonqualified
deferred compensation” within the meaning of Section 409A
and the Executive is determined to be a “specified employee”
as defined in Section 409A(a)(2)(b)(i), then such payment or benefit shall not be paid until the first payroll
date to occur following the six-month anniversary of the Termination Date or, if earlier, on the Executive’s
death (the “Specified Employee Payment Date”).
The aggregate of any payments that would otherwise have been paid before the Specified Employee Payment Date (without interest) shall
be paid to the Executive in a lump sum on the Specified Employee Payment Date and thereafter, any remaining payments shall be paid without
delay in accordance with their original schedule.

 

17.3            
Reimbursements.
To the extent required by Section 409A, each reimbursement or in-kind benefit provided under this Agreement shall be provided in accordance
with the following:

 

(a)                
the amount of expenses eligible for reimbursement, or in-kind benefits provided, during each calendar
year cannot affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in any other calendar year;

 

(b)               
any reimbursement of an eligible expense shall be paid to the Executive on or before the last day
of the calendar year following the calendar year in which the expense was incurred; and

 

(c)                
any right to reimbursements or in-kind benefits under this Agreement shall not be subject to liquidation
or exchange for another benefit.

 

18.          
Notification
to Subsequent Employer. For a period of one year after the Executive’s
Termination Date, the Executive agrees to notify any subsequent employer of the restrictive covenants sections contained in this Agreement.

 

19.          
Successors
and Assigns. This Agreement is personal to the Executive and shall not be assigned by the Executive.
Any purported assignment by the Executive shall be null and void from the initial date of the purported assignment. The Company may assign
this Agreement to any successor or assign (whether direct or indirect, by purchase, merger, consolidation, or otherwise) to all or substantially
all of the business or assets of the Company. This Agreement shall inure to the benefit of the Company and permitted successors and assigns.

 

20.          
Notice.
Notices and all other communications provided for in this Agreement shall be in writing and shall be delivered personally or sent by registered
or certified mail, return receipt requested, or by overnight carrier to the parties at the addresses set forth below (or such other addresses
as specified by the parties by like notice):

 

If to the Company:

 

Enochian Biosciences, Inc.

Attn: Luisa Puche, Chief Financial
Officer

Century City Medical Plaza

2080 Century Park East, Suite
906

Los Angeles, CA 90067

 

And with email copies to:

 

Clayton Parker

K&L Gates, LLP

Southeast Financial
Center, Suite 3900

200 South Biscayne
Boulevard

Miami, FL 33131-2399

 

    9 

     

    

 

If to the Executive:

 

Mark Dybul

 

____________________________

 

____________________________

 

____________________________

 

21.          
Representations
of the Executive. The Executive represents and warrants to the Company that:

 

(a)                
The Executive’s acceptance of employment with the Company
and the performance of his or her duties hereunder will not conflict with or result in a violation of, a breach of, or a default under
any contract, agreement, or understanding to which he/she is a party or is otherwise bound.

 

(b)               
The Executive’s acceptance of employment with the Company
and the performance of his or her duties hereunder will not violate any non-solicitation, non-competition, or other similar covenant or
agreement of a prior employer.

 

(c)                
Upon the execution and delivery of this Agreement by the Company, this Agreement shall be the valid
and binding obligation of the Executive, enforceable in accordance with its terms

 

22.          
Taxes.
Under this Agreement, the Company may withhold from any payment or the Executive’s compensation
that is required to be made amounts sufficient to satisfy applicable withholding requirements under any federal, state, or local law,
impute income to the Executive, as required under applicable law, or subject such payments to applicable deductions.

 

23.          
Protected Rights. Notwithstanding any other provision
of this Agreement, nothing contained in this Agreement limits the Executive’s
ability to file a charge or complaint with the Equal Employment Opportunity Commission, the National Labor Relations Board, the Occupational
Safety and Health Administration, the Securities and Exchange Commission or any other federal, state or local governmental agency or commission
(collectively, “Government Agencies”),
restrict or impede the Executive from exercising protected rights to the extent that such rights cannot be waived by agreement, including
but not limited to the Executive’s Section 7 rights under
the National Labor Relations Act, or restricts the Executive from providing truthful information in response to a lawfully issued subpoena
or court order. Further, this Agreement does not limit the Executive’s
ability to communicate with any Government Agencies or otherwise participate in any investigation or proceeding that may be conducted
by any Government Agency, including providing documents or other information, without notice to the Company. This Agreement does not,
in any way restrict the Executive’s rights to communicate
with any Government Agency to report suspected unlawful conduct or from complying with any applicable law or regulation or a valid order
of a court of competent jurisdiction or an authorized Government Agency, provided that such compliance does not exceed that required by
the law, regulation, or order. The Executive shall promptly provide written notice of any such order to the Company. Nothing
in this Agreement shall infringe, limit, or restrict any rights Employee has under applicable law to discuss terms and conditions of employment.
Moreover, nothing in this Agreement prohibits Employee from disclosing information about unlawful acts in
the workplace, including but not limited to information pertaining to sexual harassment or any other unlawful or potentially unlawful
conduct. 

 

24.          
Survival.
Upon the expiration or other termination of this Agreement, the respective rights and obligations of the parties hereto shall survive
such expiration or other termination to the extent necessary to carry out the intentions of the parties under this Agreement.

 

    10 

     

    

 

25.          
Acknowledgement
of Full Understanding. THE EXECUTIVE ACKNOWLEDGES AND AGREES THAT HE/SHE HAS FULLY READ, UNDERSTANDS
AND VOLUNTARILY ENTERS INTO THIS AGREEMENT. THE EXECUTIVE ACKNOWLEDGES AND AGREES THAT HE/SHE HAS HAD AN OPPORTUNITY TO ASK QUESTIONS
AND CONSULT WITH AN ATTORNEY OF HIS OR HER CHOICE BEFORE SIGNING THIS AGREEMENT. 

 

[SIGNATURE PAGE FOLLOWS]

 

    11 

     

    

 

IN WITNESS WHEREOF, the parties
hereto have executed this Agreement as of the date first above written.

 

	MARK
    DYBUL	 	ENOCHIAN
    BIOSCIENCES, INC., a Delaware corporation
	 	 	 
	Signature:	/s/
    Mark Dybul	 	By:	 /s/
Luisa Puche
	Print
    Name:	Mark
    Dybul	 	Name:
    	Luisa
    Puche
	 	 	Title:
    	Chief
    Financial Officer

 

    12 

     

    

 

ADDENDUM A

 

CONFIDENTIAL AND PROPRIETARY INFORMATION AGREEMENT

 

Mark
Dybul (“Employee”)
understands that, by virtue of Employee’s
employment with Enochian BioSciences, Inc. (“the
Company”),
Employee will acquire and/or be exposed to confidential and proprietary information of Company, and thus, for good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, Employee acknowledges and accepts this Confidential and Proprietary Information
Agreement (“Agreement”):

 

1.             
Confidential Information

 

1.1       Confidential
Information. Company may, in its discretion, convey to Employee, either verbally, or by written, printed, graphic, pictorial, electronic,
or other forms of communication, certain confidential, trade secret, and/or proprietary information of Company (“Confidential
Information”).
“Confidential
Information” is
to be broadly defined and includes all information that has or could have actual or potential commercial or economic value or other utility
in the business of Company (including its affiliates, partners, principals, employees, representatives, and contractors), its customers,
and all others with whom it does business. Confidential Information includes, but is not limited to all forms and types of financial,
business, scientific, technical, economic, or engineering information, including but not limited to Developments (as defined in this Agreement);
plans; devices; designs; prototypes; techniques; methods; processes; procedures; programs; codes; inventions (whether or not patentable
or reduced to practice); innovations; improvements; know-how; treatments; drawings; sketches; specifications; patterns; models; sales
strategies; sales forecasts; product knowledge; customer lists; customer identities; customer contact information; customer personal information;
customer leads and referral sources; customer profiles; customer terms; customer preferences; customer purchasing habits and history;
customer contracts; formulas; pricing; schedules; marketing and sales strategies, plans, and materials; financial information and bank
statements; forms, policies and procedures; personnel records and data; compensation data; employee rosters and contact information; names
of suppliers; contracts with employees and third parties; payments to third parties; licensing deals; profits and margins; analytics and
modeling; legal documents; business plans; forecasts; works in progress; research and development; pending projects and proposals; collaboration
contacts and agreements (whether potential or realized); potential or current joint venture contacts and agreements; investor, lender,
and supplier information; technological data; database; internal communications; manuals; training materials; compilations; software programs;
source code; object code; and all other confidential, proprietary and/or trade secret information whether tangible or intangible in any
document, form or medium whether or how stored, compiled, or memorialized physically, electronically, graphically, photographically, or
in writing (whether merely remembered or embodied in a tangible or intangible form or medium). Confidential Information also includes
any information described in this Section that is related to Company’s
customers or business partners, or that Company obtains from a third party and treats as proprietary or confidential, whether or not owned
or developed by Company. Confidential Information does not include (i) Developments and/or information that has been independently developed
by Employee under California Labor Code Sec. 2870; (ii) was known to the public prior to its disclosure to Employee; (iii) becomes generally
known to the public subsequent to disclosure to Employee through no wrongful act of Employee; or (iv) that Employee is required to disclose
by applicable law, regulation or legal process (provided that Employee provides Company with prior notice of the contemplated disclosure
and cooperates with Company at its expense in seeking a protective order or other appropriate protection of such information). Confidential
Information is and shall remain the property of Company. By disclosing information to Employee, Company does not grant any express or
implied right to Employee to or under Company’s
patents, copyrights, trademarks, trade dress, trade secrets and/or any other proprietary right.

 

    13 

     

    

 

1.2       Nondisclosure.
Employee understands that Company has the right to insist on the undivided loyalty of its employees. Employee acknowledges and agrees
that all Confidential Information is maintained as a trade secret and is the sole and exclusive property of Company. Employee agrees to
hold in strict confidence and trust, both during and after Employee’s
employment with Company, all Confidential Information, and not to reveal, report, publish, disclose or transfer, directly or indirectly,
any Confidential Information to any person or entity, and not to acquire or utilize any Confidential Information for any purpose other
than those purposes approved by Company during the course and scope of Employee’s
employment with Company. Employee also agrees to refrain from any acts or omissions that would reduce the value of Confidential Information
to Company. If disclosure of part or all of Confidential Information must be made to a third party, such disclosure shall be made by Employee
only with the consent of Company and under the terms of a confidentiality or non-disclosure agreement with said third party. Employee
will not, at any time during or subsequent to his or her employment with Company, acquire, disclose, or use Confidential Information in
any unauthorized manner or in any manner detrimental to the best interests of Company. Employee will not, at any time during or subsequent
to his or her employment with Company, knowingly permit Confidential Information to be acquired by, disclosed to, or used by any competitor
of Company. If Employee originates, develops, or reduces to writing Confidential Information, Employee does so within the scope of Employee’s
performance and such Confidential Information will become for all purposes property of Company, and will be treated as Confidential Information.
Confidential Information will be entitled to all of the protections and benefits under applicable law. Employee will notify Company in
writing immediately after Employee receives a subpoena, notice to produce, or other compulsory order or process of any court of law or
government agency if such document requires or may require disclosure or other transfer of Confidential Information. Employee agrees not
to reverse engineer or attempt to derive the composition or underlying information, structure or ideas of any Confidential Information.

 

1.3       Confidential
and Proprietary Information of Others. Employee acknowledges that Company has a strict policy against using confidential or proprietary
information belonging to any other person or entity without the express permission of the owner of that information. Employee represents
and warrants that the performance by Employee of all of the terms of this Agreement will not result in any breach of any duty owed by
Employee to a third party to keep in confidence or not to use any confidential or proprietary information, knowledge or data acquired
by Employee in confidence. Employee agrees not to disclose to Company or to induce Company to use any confidential or proprietary information
belonging to any third party. Employee will not, at any time, disclose to, or discuss with, Company employees any confidential or proprietary
data belonging to Employee’s former employers,
nor will Employee bring to Company’s
premises any confidential or proprietary information belonging to Employee’s
former employers or any other third party, and will not disclose or use any such information while performing work for Company. Employee
agrees to indemnify and hold harmless Company for any damages whether monetary, punitive, or in equity caused by or the result of Employee’s
disclosure of confidential or proprietary information or any confidential information belonging to Employee’s
former employers or other entities or persons with whom Employee has a duty to not disclose confidential or proprietary information.

 

1.4       Return
of Property and Confidential Information. Upon termination of employment and at any time at the request of Company, Employee will
promptly deliver to Company all originals and copies of any notes, data, reference materials, sketches, drawings, memoranda, documents,
and records in any way incorporating or reflecting any Confidential Information or any copyrights or proprietary rights therein (whether
maintained in tangible or intangible form, computer memory or other format), and whether made or compiled by or on behalf of Employee
or made available to Employee by Company, in the possession, custody, or control of Employee. Following termination or a request to return
Confidential Information, Employee will not acquire, use, maintain, copy, or disclose any materials containing Confidential Information.
Employee will keep Confidential Information confidential in perpetuity following termination of employment. Employee will return any and
all equipment, software, keys, access cards, files and other property belonging to Company promptly upon termination of Employee’s
employment and at any time at Company’s
request. In the event of the termination of Employee’s
employment, Employee agrees to sign and deliver the “Termination
Certification” attached
hereto as Attachment A.

 

    14 

     

    

 

2.             
Competition, Solicitation & Nondisparagement

 

2.1       Restrictions
on Competition By Use of Confidential Information. Employee acknowledges that (i) the identities of, and other Confidential Information
regarding, past, current, and prospective customers and business partners of Company are confidential and proprietary and constitute trade
secrets under applicable law, and are not generally known to the public; (ii) Company uses reasonable efforts to maintain the confidentiality
of such Confidential Information; and (iii) Company expends substantial time and resources to obtain and maintain relationships with its
past, current, and prospective customers and business partners. Employee understands and acknowledges that the business requirements and
likes and dislikes of Company’s customers are
intrinsic to the value of this information. Accordingly, Employee agrees, to the extent permitted by applicable law, that Employee will
not, during or at any time after Employee’s
employment, without the prior written consent of Company, solicit any of the past, current, or prospective customers or business partners
of Company to do business with any person or entity whose business competes with the business of Company, in each case, to the extent
that the identity of, or other information regarding, such customer or business partner constitutes a trade secret of Company under applicable
law, and/or to the extent that such solicitation involves acquisition, disclosure, or use of Company’s
Confidential Information. Employee further agrees not to keep or use customer lists, customer information, and/or any other Confidential
Information to mail, e-mail, or in any other manner contact or communicate with Company’s
customers (past, present and future) for any purpose, including but not limited to soliciting business for Employee’s
own business interests or the business interests of any person or entity.

 

2.2       Nonsolicitation.
For one (1) year after termination of Employee’s
employment relationship with Company, Employee will not, either directly or indirectly, induce, solicit, recruit, or encourage any person
employed by Company to end their employment relationship with Company.

 

2.3       Noninterference.
Employee agrees not to take any action that disrupts, damages, impairs, or interferes with Company’s
contractual and/or economic relationships with any business, vendor, officer, director, agent, employee, contractor, or other person or
entity; provided, however, Employee will be permitted to do business with or be hired by any vendor, agent or contractor of the Company
after one (1) year after termination of Employee’s
employment relationship with the Company. For the avoidance of doubt, this covenant shall not be interpreted to extend the one (1) year
post-termination duration of the covenants set forth in Sections 2.2 and 2.6 hereof. 

 

2.4       Nondisparagement.
Except as otherwise provided in Section 23 of the Employment Agreement and/or applicable law, both during and after Employee’s
employment with Company, Employee will not make any representation or statement, whether written or oral, to any person or entity, including,
but not limited to, former, current and potential customers, vendors, business partners, employees, or competitors of Company or any of
Company’s
affiliates, which reflects any opinion, judgment, observation or representation that may defame, disparage, harm, or otherwise reflect
negatively on Company or its officers, directors, or employees. 

 

2.5       Prohibition
on Competition During Employment. During the course of Employee’s
employment with Company, Employee will not directly or indirectly compete with Company or aid any other individual or organization in
competition with Company.

 

2.6       Prohibition
on Competition After Employment. For one (1) year
after termination of Employee’s
employment relationship with Company, in addition to and independent of all other obligations of Employee contained herein, following
the termination of Employee’s
employment with Company, except as may otherwise be provided by applicable law, Employee will not directly or indirectly compete with
Company or aid any other individual or organization in competition with Company, provided that Company continues to pay Employee’s
Base Salary of $850,000 per annum as consideration for such prohibition on competition.

 

    15 

     

    

 

2.7       Subpoenas;
Cooperation in Defense of Company. If Employee is served with any subpoena or other compulsory judicial or administrative process
calling for production of Confidential Information or if Employee is otherwise required by law or regulation to disclose Confidential
Information, Employee will promptly notify the Company before making any such production or disclosure and Employee also will provide
Company with such information as it may reasonably request to take such action as it deems necessary. Employee agrees to cooperate reasonably
with Company, whether during Employee’s employment
or thereafter, in the prosecution or defense of all threatened claims or actual litigation in which Company is or may become a party,
whether now pending or hereafter brought, in which Employee has knowledge of relevant facts or issues, with the understanding that the
Company will pay all of Employee’s
reasonable expenses and, if Employee is no longer employed by Company and is required to devote more than ten (10) hours of time in any
12-month period, he will be compensated for such time at a daily rate to be mutually agreed upon by Company and Employee.

 

3.             
Disclosure of Developments to Company

 

3.1       Developments.
As used in this Agreement, “Developments”
means any work of authorship, discovery, improvement, invention,
design, graphic, source, HTML and other code, trade secret, technology, algorithms, computer program, audio, video or other files or content,
idea, design, process, technique, know-how and data, whether or not patentable or copyrightable. Employee agrees to maintain adequate
and current written records and promptly disclose in writing to Company, all Developments, made, discovered, conceived, reduced to practice
or developed by Employee, either alone or jointly with others, during the term of Employee’s
service for Company.

 

3.2       Disclosure
of Developments. Employee will disclose to Company
all Developments made, discovered, conceived, reduced to practice, or developed by Employee, either alone or jointly with others, within
six (6) months after the termination of Employee’s
service with Company which resulted, in whole or in part, from Employee’s
prior service for Company. Such disclosures shall be received by Company in confidence (to the extent such Developments are not assigned
to Company and do not extend the assignment made below). Employee will not disclose Developments covered by this Section to any person
outside Company unless Employee is requested to do so by Company.

 

4.             
Ownership of Developments

 

4.1       Generally.
Employee agrees that all Developments that Employee makes, discovers, conceives, reduces to practice or develops (in whole or in part,
either alone or jointly with others) during Employee’s
service for Company shall be the sole property of Company to the maximum extent permitted by Section 2870 of the California Labor Code
or any like statute of any other state. Section 2870 provides as follows:

 

Any
provision in an employment agreement which provides that an employee shall assign, or offer to assign, any of his or her rights in an
invention to his or her employer shall not apply to an invention that the employee developed entirely on his or her own time without using
the employer’s equipment, supplies, facilities,
or trade secret information except for those inventions that either:

 

(a)       Relate
at the time of conception or reduction to practice of the invention to the employer’s
business, or actual or demonstrably anticipated research or development of the employer.

 

(b)       Result
from any work performed by the employee for his employer.

 

To the extent a provision in
an employment agreement purports to require an employee to assign an invention otherwise excluded from being required to be assigned under
subdivision (a), the provision is against the public policy of this state and is unenforceable.

 

This assignment shall not extend
to Developments the assignment of which is prohibited by Labor Code Section 2870.

 

    16 

     

    

 

Employee
will advise Company promptly in writing of any inventions, original works of authorship, developments, improvements or trade secrets that
Employee believes meet the criteria in Section 2870, above, and Employee will provide to Company in writing all evidence necessary to
substantiate that belief. Employee understands that Company will keep in confidence and will not disclose to third parties without Employee’s
consent any such information disclosed in writing to Company for this purpose. Employee identifies all such works here (attach additional
pages if necessary):

 

 

 

  

 

4.2       Works
Made for Hire. Company shall be the sole owner of all patents, patent rights, copyrights, trade secret rights, trademark rights and
all other intellectual property or other rights in connection with Developments. Employee further acknowledges and agrees that such Developments,
including, without limitation, any computer programs, programming documentation, and other works of authorship, are “works
made for hire” for
purposes of Company’s
rights under copyright laws. Employee hereby assigns to Company any and all rights, title and interest Employee may have or acquire in
such Developments.

 

4.3       Cooperation.
Employee agrees to perform, during and after Employee’s
service for Company, all acts deemed necessary or desirable by Company to permit and assist it, at Company’s
expense, in further evidencing and perfecting the assignments made to Company under this Agreement and in obtaining, maintaining, defending
and enforcing patents, patent rights, copyrights, trademark rights, trade secret rights or any other rights in connection with such Developments
and improvements thereto in any and all countries. Such acts may include, but are not limited to, execution of documents and assistance
or cooperation in legal proceedings. Employee hereby irrevocably designates and appoints Company and its duly authorized officers and
agents, as Employee’s
agents and attorney-in-fact to act for and on Employee’s
behalf and instead of Employee, to execute and file any documents, applications or related findings and to do all other lawfully permitted
acts to further the purposes set forth above, including, without limitation, the perfection of assignment and the prosecution and issuance
of patents, patent applications, copyright applications and registrations, trademark applications and registrations or other rights in
connection with such Developments and improvements thereto with the same legal force and effect as if executed by Employee.

 

5.             
Remedies

 

Employee agrees that any breach
of this Agreement will be grounds for discipline, up to and including termination and legal action. Employee shall notify Company immediately
upon discovery of any unauthorized acquisition, disclosure, or use of Confidential Information, or any other breach of this Agreement
by Employee or otherwise known to Employee, and will cooperate with Company in every reasonable way to help Company regain possession
of the Confidential Information and prevent improper, unauthorized and/or unlawful acts. Notwithstanding any arbitration agreement between
Employee and Company, in the event of a breach, or a threatened breach, by Employee of this Agreement, Company shall have the right to
have the provisions of this Agreement specifically enforced by any Court having equity jurisdiction, and shall not be required to mediate
or arbitrate, because breach or threatened breach will cause irreparable injury to Company and money damages will not provide an adequate
remedy. Thus, Company shall be entitled to injunctive relief, specific performance, or both, and shall be entitled to have entered a civil
seizure, temporary restraining order, preliminary or permanent injunction, or order compelling specific performance, without the necessity
of posting a bond or other security, in addition to whatever other remedies may be available at law or otherwise, to the extent allowed
by law. Company has the right to recover damages for all losses, actual and contingent, and the right to require Employee to account for
and pay over to Company all profits or other benefits derived or received by Employee as a result of any transactions constituting such
a breach.

 

    17 

     

    

 

6.             
Authorization to Notify New Employer

 

Employee hereby authorizes
Company to notify Employee’s new employer about Employee’s
rights and obligations under this Agreement following the termination of Employee’s
service for Company.

 

7.             
Defense of Trade Secrets Act

 

The federal Defense of Trade Secrets
Act provides for the following immunities: (1) An individual shall not be held criminally or civilly liable under any federal or state
trade secret law for the disclosure of a trade secret that (A) is made (i) in confidence to a federal, state, or local government official,
either directly or indirectly, or to an attorney, and (ii) solely for the purpose of reporting or investigating a suspected violation
of law; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. (2)
An individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret
to the attorney of the individual and use the trade secret information in the court proceeding, if the individual (A) files any document
containing the trade secret under seal and (B) does not disclose the trade secret, except pursuant to court order.

 

I acknowledge the foregoing provisions and agree
to comply with the terms of this Agreement, including all post-termination obligations set forth herein, as a material condition of my
employment with the Company.

 

	/s/
    Mark Dybul 	 	Date:	08/11/2021
	Mark
    Dybul	 	 

 

    18 

     

    

 

ATTACHMENT A

 

TERMINATION CERTIFICATION

 

This is to certify that I do not
have in my possession, nor have I failed to return, any devices, records, data, notes, reports, proposals, lists, files, correspondence,
specifications, drawings, blueprints, sketches, materials, equipment, other documents or property, or reproductions of any aforementioned
items belonging to the Company.

 

I
further certify that I have complied with all the terms of the Company’s
Confidential and Proprietary Information Agreement signed by me, including the reporting of any inventions and original works of authorship
(as defined therein), conceived or made by me (solely or jointly with others) covered by that Agreement.

 

I
understand that post-termination obligations exist under the Company’s
Confidential and Proprietary Information Agreement and that the Company may seek any and all avenues of legal redress should I breach
that Agreement. I further certify that I have complied with terms of that Agreement and will comply with all post-termination obligations
under that Agreement.

 

	 	 	Date:	 
	Mark
    Dybul	 	 

 

    A-1

     

    

 

ADDENDUM B

 

ARBITRATION AGREEMENT

 

Enochian
BioSciences, Inc. (“Employer”)
and Mark Dybul (“Employee”)
agree to this Arbitration Agreement (the “Agreement”):

 

1.       “Employer”
Defined.
For purposes of this Agreement, “Employer”
refers to Enochian BioSciences, Inc. (“Company”)
and its present and former trustees, officers, directors, owners, shareholders, parent companies, subsidiaries, holding companies, employees,
agents, affiliated entities, insurers, attorneys, successors, predecessors, and assigns.

 

2.       Governing
Law. The Federal Arbitration Act governs this Agreement
to the maximum extent permitted by law.

 

3.       Claims
Covered. Arbitration is the most traditional form
of private dispute resolution. Arbitration is a binding procedure. The arbitrator selected by the parties (usually an attorney or retired
judge) renders a decision at the end of an arbitration hearing, and that decision is final and binding, subject only to a very limited
court review. Understanding and acknowledging the nature of arbitration, Employer and Employee voluntarily and mutually consent to the
resolution by final and binding arbitration of all disputes, claims or controversies of any kind between them, whether now in existence
or that may arise in the future, including but not limited to all disputes arising out of, relating to, and/or in connection with Employee’s
employment with Employer and/or termination of employment, to the fullest extent allowed by law, including but not limited to any issue
concerning the formation, existence, validity, arbitrability, and/or enforceability of this Agreement (“Claims”),
with the exception of Claims Not Covered, as provided under Section 4 of this Agreement. Claims include, but are not limited to,
the following, whether brought by Employer or Employee: wage and hour claims, including but not limited to claims for overtime, minimum
wage, vacation, paid sick leave, paid time off, meal and/or rest breaks, paystub disclosures, unpaid wages, deductions, expense reimbursement,
and claims for wages under Labor Code Section 558; claims for breach of any contract or covenant (express or implied); tort claims; claims
for discrimination, harassment, and/or retaliation based on race, color, national origin, ancestry, sex, gender, sexual orientation, age,
religion, creed, physical or mental disability, political affiliation, medical condition, marital status, family care, parental status,
citizenship status, military and veteran’s
status, pregnancy and related conditions, genetic information, and any other basis protected by applicable law; claims for benefits; theft,
embezzlement, gross negligence, destruction of property, conversion, and overpayment of wages; misappropriation of property, trade secrets
and/or confidential information; breach of the duty of loyalty; breach of fiduciary duty; interference with contract; fraud; unfair competition;
gross negligence; any claim for alleged wrongful conduct by Employee of any kind; and claims for violation of any federal, state, local,
or other law, including but not limited to Title VII of the Civil Rights Act of 1964, the California Fair Employment and Housing Act,
the Age Discrimination in Employment Act, the Americans with Disabilities Act, the California Labor Code, the Family and Medical Leave
Act, the California Family Rights Act, the Equal Pay Act, the Fair Pay Act, the False Claims Act, the Sarbanes-Oxley Act, ERISA, the California
Industrial Welfare Commission Orders, the Fair Labor Standards Act, and the California Unfair Competition Act.

 

    B-1

     

    

 

4.       Claims
Not Covered. This Agreement does not cover claims
for workers’ compensation,
state or federal disability benefits, or unemployment compensation benefits; claims or charges filed with the Equal Employment Opportunity
Commission, California Department of Fair Employment and Housing, National Labor Relations Board (NLRB), Securities and Exchange Commission,
OSHA or Cal-OSHA, California Department of Labor Standards Enforcement, U.S. Department of Labor, and/or any other governmental agency;
claims under an employee welfare benefit or pension plan that specifies that its claims procedure shall culminate in an arbitration procedure
different from this one; claims for injunctive relief relating to trade secrets, confidential information, patents, copyright, trademarks,
or other intellectual property; claims under the Private Attorneys General Act (PAGA); and claims that cannot be legally arbitrated. Such
claims may be presented in the appropriate forum. In addition, nothing in this Agreement waives Employee’s
rights under Section 7 of the National Labor Relations Act.

 

5.       Class
and Collective Action Waiver. Employee waives the
right to bring any Claim on a class and/or collective action basis, in court, arbitration, or in any other forum, as a named or unnamed
plaintiff, participant, class member or in any other capacity. The arbitrator shall have no power to arbitrate class and/or collective
action Claims brought by Employee or including Employee. Employee further agrees that if Employee is included in any class and/or collective
action of covered Claims, Employee will take all steps necessary to opt out or refrain from opting in. Notwithstanding this waiver, Employee
has a statutory right under the National Labor Relations Act to act concertedly on behalf of Employee and others, and to exercise all
rights under the Act, including but not limited to Section 7 rights, the right to file statutory claims for public injunctive relief,
and the right to file unfair labor practice charges with the National Labor Relations Board.

 

6.       Arbitration
Procedures. As to arbitrable Claims, the parties
shall select a neutral arbitrator by mutual agreement from the panel of JAMS. Except as otherwise provided in this Agreement, the JAMS
Employment Rules & Procedures, available online (https://www.jamsadr.com/rules-employment) or from Human Resources, shall apply. Prior
to beginning work, the Arbitrator must disclose all conflicts of interest. Employer will be responsible for paying all fees and costs
unique to the arbitration, including the fees and costs of the Arbitrator. The arbitration shall be confidential to the fullest extent
permitted by law. Subject to applicable law or the parties’
written agreement, information exchanged during discovery and
presented during the course of the arbitration proceedings shall be kept confidential and shall not be used or disclosed except as necessary
for purposes of the arbitration. The arbitration award shall not be published except with the prior written consent of each of the parties.
Each party shall have the right to be represented by an attorney, and each party shall pay its own costs and attorneys’
fees (other than arbitrator’s
fees and costs unique to the arbitration process, which will be paid for by Employer), except whereas otherwise provided by applicable
law regarding attorney’s
fees awards to a prevailing party. The Arbitrator will apply whatever statute(s) of limitations applicable by law to the parties’
Claim(s). Each party shall have the right to conduct discovery
sufficient to vindicate the Claims at issue, including access to essential documents and witnesses, as determined by the Arbitrator. The
Arbitrator shall issue a signed written decision setting forth the basis for the decision and summarizing the key issues and the essential
findings and conclusions upon which the award is based. The Arbitrator shall have full authority to award all relief available in a court
of law, including but not limited to compensatory and punitive damages, reinstatement, costs, and attorneys’
fees as provided by contract or statute. Judgment upon the
award may be entered in any court having proper jurisdiction. 

 

7.
       Mediation. Any
Claim required to be arbitrated under this Agreement shall be submitted to mediation in a manner agreed to by Employee and Employer. Employee
and Employer agree to use mediation to attempt to resolve any such Claim prior to filing for arbitration under this Agreement. Employee
and Employer will select a mediator agreeable to both parties. The costs of the mediation and fees of the mediator will be borne entirely
by Employer. The parties will cooperate with the mediator on mediation arrangements, including time and place for mediation, who will
attend or participate, and what information will be exchanged.

 

    B-2

     

    

 

8.       Additional
Provisions. The provisions of this Agreement survive
cessation of Employee’s
employment and continue thereafter in perpetuity. This Agreement is the entire agreement between the parties and supersedes all prior
agreements between them with regard to the subject matter of this Agreement. Employee has the right to consult with counsel of Employee’s
choice concerning this Agreement. No party is relying on any representations, oral or written, on the effect, enforceability, or meaning
of this Agreement, except as set forth in this Agreement. If any part of this Agreement is held unlawful or unenforceable, the remainder
shall be enforceable to the fullest extent permitted by law. This agreement can be executed in counterparts, each of which may be deemed
an original and which together shall constitute one instrument.

 

Employer and Employee fully and voluntarily consent
and agree to the terms of this Agreement.

 

	MARK
    DYBUL	 	ENOCHIAN
    BIOSCIENCES, INC., a Delaware corporation
	 	 	 
	Signature:	/s/
    Mark Dybul	 	By:	 /s/
Luisa Puche
	Print
    Name:		 	Name:
    	Luisa
    Puche
	 	 	Title:
    	Chief
    Financial Officer

  

B-3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00332-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00332-of-00352.parquet"}]]